ArticleScientific reports2017

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells.

Majid Momeny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.